News
Pembrolizumab significantly reduced the risk of event free survival events by 30% compared with standard of care.
In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9% with early and late discontinuation and nondiscontinuation, respectively.
HealthDay News — For critically ill adults with sepsis, statin use is associated with reduced mortality, according to a study published online June 5 in Frontiers in Immunology.
The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).
Widaplik is indicated for the treatment of hypertension, including as initial treatment, to lower blood pressure.
Individuals with recall related inquiries can contact Amneal Pharmaceuticals at (833) 582-0812 or via email at [email protected]. Adverse reactions should be reported to ...
Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for the relief of moderate to severe nasal ...
Some FDA staff said Elsa often gave wrong answers, what experts call “hallucinations”, and has to be double-checked.
The US Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr named 8 new members to the Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization ...
HealthDay News — Mailed self-collection (SC) kits may increase participation in cervical cancer screening, according to a study published online June 6 in JAMA Internal Medicine.
The approval was based on two phase 1 crossover studies, which compared zanubrutinib tablets with the capsule formulation in healthy adult participants.
HealthDay News — Health care employment growth decreased during the pandemic but recovered by 2024, according to a research letter published online June 5 in the Journal of the American Medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results